Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

Industry standards for surface finish help define the specifications of the instruments, how they are used, the results they provide and how they can be tested for performance. 26 Feb 2025 Marathon ...

Dancers smashing plates at Opa Hollywood, as per Greek tradition. Credit: Greek Reporter The sound of a plate smashing, shattering loudly as it meets the floor, is distinctive and tends to turn heads ...